MARKET WIREYahoo Finance • 13h ago
Molina Healthcare (MOH) Stock May Trade At A Discount Despite Reaffirmed 2026 GuidanceYahoo Finance report covering Molina Healthcare Inc (MOH) market action, institutional positioning, and fundamental catalysts.
Why MOH Stock surged +2.93% Today — RQD Quant Desk Flash
$204.78 +2.93% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $205.47
Molina Healthcare Inc (MOH) carries a Roarable Rating of D+ (Sell) with 54/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D+ • SELL / AVOID
Cap $10.39B
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on MOH Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is MOH stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-02, Molina Healthcare Inc (NYSE: MOH) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 54/100 at a spot price of $204.78 (+2.93% 1D, market cap $10.39B). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 14/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 9/20. Across 1016 tracked Health Care issuers, MOH ranks #237 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does MOH compare to CAI and HSIC in the Health Care sector?
▼
Within the Health Care sector (Medical Specialities), MOH carries a Roarable D+ (54/100 RQD), trailing P/E of 22.0x, gross margin of 13.1%, and ROIC of 17.2%. By comparison, CAI (Caris Life Sciences Inc.) holds a B grade (73/100 RQD, P/E N/A, ROIC 4.4%, cap $10.21B) and HSIC (Henry Schein Inc.) posts a C- grade (60/100 RQD, P/E 23.0x, ROIC 11.2%, cap $9.63B). Among the 5-stock peer group, MOH leads on earnings multiple (22.0x) while MOH leads on capital efficiency (17.2% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for MOH?
▼
Per MOH's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001179929), Molina Healthcare Inc generated $45.43B in revenue (+11.7% YoY), $472.0M in net income, and -$636.0M in free cash flow against $15.56B in total assets and $3.77B in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $205.48 (+0.34%)🧬 Disciplined Float (+0.80% YoY Shares)⚙️ Cash Engine: 10/20 (D) • 0% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record: Scores of 54/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.7% avg 90D alpha vs SPY • 51.0% hit rate — wait for RQD ≥ 70 breakout).
Audit Bucket Track Record →RQD QUANT TACHOMETERSELL / AVOID • D+
2-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw D · Rk C-
Each axis scored 0–20
12M PRICE TARGET CONE-1.8% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for MOH)Realized 20D OHLCV Swing Band: ±9.3%
Deterministic 5-Pillar Attribution (54/100 Composite)
🔍 WHY MOH SCORES 54/100 (D+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+14/20 pts (26% of score)
Altman Z-Score 4.34 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 4/9
▲ #2 Bullish Driver: Whale & Options Positioning+11/20 pts (20% of score)
20D Institutional Volume Accumulation (±9.3% realized swing band)
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution9/20 pts (-11 pt drag)
Disciplined Float (+0.80% YoY Shares) & executive Form 4 sales trim 11 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade C+$209.50+4.9% Next Q
62
Q2 (-2Q)Grade C$219.72-9.2% Next Q
59
Q3 (-1Q)Grade C$199.46+2.7% Next Q
57
CurrentGrade D+$204.78-0.7% Hist 90D α
54
Trajectory: C+ (62) → D+ (54)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a MOH Turnaround Squeeze
While MOH currently carries a cautious 54/100 (D+) rating due to Insider Conviction & Share Dilution (9/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Health Care with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($200.57) and Max Pain ($215.02) forces dealer call-delta covering toward $257.13.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.80% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $MOH• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “MOH Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why MOH Stock surged +2.93% Today — RQD Quant Desk Flash
Molina Healthcare Inc (MOH) surged +2.93% to $204.78, trading at 68% of its 52-week range ($121.06 – $244.89). Stretched risk/reward at 22x P/E (17% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 68% of its 52-week range ($121.06 – $244.89) with RSI-14 at 46.2 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±9.3% around $204.78 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D+ (Sell) backed by 13.1% gross margin and $0 annual free cash flow.
Live MOH Headlines & Catalysts
MARKET WIREForbes • 16h ago
Molina HealthcareForbes report covering Molina Healthcare Inc (MOH) market action, institutional positioning, and fundamental catalysts.
MARKET WIRESeeking Alpha • 19h ago
Molina Healthcare: Paying 21x For A Recovery That Hasn't Happened YetSeeking Alpha report covering Molina Healthcare Inc (MOH) market action, institutional positioning, and fundamental catalysts.
MARKET WIRETradingView • 22h ago
Molina Healthcare’s (NYSE:MOH) Q3 2026 sales top estimatesTradingView report covering Molina Healthcare Inc (MOH) market action, institutional positioning, and fundamental catalysts.
MARKET WIRESimply Wall St • 1d ago
Molina Healthcare (MOH) Stock May Look Reasonable On Its Sales BaseSimply Wall St report covering Molina Healthcare Inc (MOH) market action, institutional positioning, and fundamental catalysts.
RISK WATCHYahoo Finance • 1d ago
Molina Healthcare (MOH) Stock Drops After Q3 Results Expose Margin SqueezeYahoo Finance report covering Molina Healthcare Inc (MOH) market action, institutional positioning, and fundamental catalysts.
RISK WATCHGuruFocus • 1d ago
Molina Healthcare Inc (MOH) Shares Fall 3.5% -- What GF Score of 80 Tells InvestorsGuruFocus report covering Molina Healthcare Inc (MOH) market action, institutional positioning, and fundamental catalysts.
CATALYSTGuruFocus • 1d ago
Molina Healthcare (MOH) Shares Dip After Q3 Beat Despite Strong Revenue GrowthGuruFocus report covering Molina Healthcare Inc (MOH) market action, institutional positioning, and fundamental catalysts.
MARKET WIREYahoo • 4d ago
Molina: 3 Key Takeaways for Long-Term InvestorsMedicaid margins may have bottomed as state rate increases align with care costs, setting up a multiyear recovery cycle.
CATALYSTYahoo • 4d ago
Lucie and CHOICE Broaden the Growth Runway for Oscar HealthOscar Health is broadening its growth beyond ACA insurance through Lucie and CHOICE, adding fee-based opportunities as its shares rise 116% year to date.
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring MOH)
- ✓Walkthrough of MOH's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
MOH // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +4.73%📐 HORIZONTAL RANGE
2026-11-02O $198.1H $204.8L $198.1C $204.8VOL 635.7K
RES: $227.9SUP: $174.2SMA50: $200.6SMA200: $185.0
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
MOH Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
15.7%/yr Implied 5Y Growth
vs. +11.7% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on MOH today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for MOH. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for MOH today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (MOH)
Health Care Rank #237 of 1016
⚔️ CAI vs MOH Full Matrix →
1. Head-to-Head Health Care Peer Comparison (MOH vs. CAI, HSIC, OSCR, GRAL)
Industry: Medical Specialities (41 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, Molina Healthcare Inc (MOH) ranks #237 by composite RQD confidence (54/100, grade D+) and #108 by equity capitalization ($10.39B). Within this direct 5-issuer industry benchmark cohort, MOH leads on earnings valuation at 22.0x trailing P/E, while MOH leads on capital efficiency and profitability with 17.2% ROIC and 13.1% gross margin. CAI currently holds the highest overall quantitative score in the immediate peer group at 73/100 (B) compared with MOH at 54/100 (D+).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| MOH
ACTIVE
Molina Healthcare Inc | D+ | 54/100 | 22.0x | 13.1% | 17.2% | +2.93% | $10.39B | Benchmark Subject |
| CAI Caris Life Sciences Inc. | B | 73/100 | — | — | 4.4% | -5.01% | $10.21B | /cai-vs-moh → |
| HSIC Henry Schein Inc. | C- | 60/100 | 23.0x | 31.1% | 11.2% | -1.80% | $9.63B | /hsic-vs-moh → |
| OSCR Oscar Health Inc. | D+ | 53/100 | — | — | -35.0% | -1.36% | $9.50B | /oscr-vs-moh → |
| GRAL GRAIL Inc. | D+ | 54/100 | — | — | -18.0% | -9.75% | $7.10B | /gral-vs-moh → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001179929In its most recent audited fiscal period (FY2025, filed 2025-12-31), Molina Healthcare Inc (MOH) reported GAAP revenue of $45.43B (+11.7% vs. FY2024 revenue of $40.65B , and +33.3% cumulative change since FY2023) , GAAP net income of $472.0M, operating cash flow of -$535.0M, and free cash flow of -$636.0M (-216.9% YoY). On the balance sheet, MOH closed FY2025 with $15.56B in total assets against $3.77B in total debt (Altman Z-Score: 4.34, Piotroski F-Score: 4/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $45.43B | $472.0M | -$535.0M | -$636.0M | $15.56B | $3.77B |
| FY2024 (FY) | 2024-12-31 | $40.65B | $1.18B | $644.0M | $544.0M | $15.63B | $2.92B |
| FY2023 (FY) | 2023-12-31 | $34.07B | $1.09B | $1.66B | $128.8M | $40.89B | $9.57B |
3. MOH Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs MOH stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-02, Molina Healthcare Inc (NYSE: MOH) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 54/100 at a spot price of $204.78 (+2.93% 1D, market cap $10.39B). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 14/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 9/20. Across 1016 tracked Health Care issuers, MOH ranks #237 in composite RQD confidence.
How does MOH compare to CAI and HSIC in the Health Care sector?
Within the Health Care sector (Medical Specialities), MOH carries a Roarable D+ (54/100 RQD), trailing P/E of 22.0x, gross margin of 13.1%, and ROIC of 17.2%. By comparison, CAI (Caris Life Sciences Inc.) holds a B grade (73/100 RQD, P/E N/A, ROIC 4.4%, cap $10.21B) and HSIC (Henry Schein Inc.) posts a C- grade (60/100 RQD, P/E 23.0x, ROIC 11.2%, cap $9.63B). Among the 5-stock peer group, MOH leads on earnings multiple (22.0x) while MOH leads on capital efficiency (17.2% ROIC).
What are the biggest fundamental strengths and SEC risk factors for MOH?
Per MOH's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001179929), Molina Healthcare Inc generated $45.43B in revenue (+11.7% YoY), $472.0M in net income, and -$636.0M in free cash flow against $15.56B in total assets and $3.77B in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is MOH trading relative to its 50-day, 200-day, and 52-week technical levels?
MOH last traded at $204.78 (+2.93% on volume of 1,752,979 shares), positioning the stock +2.10% above its 50-day simple moving average ($200.57) and +10.71% above its 200-day simple moving average ($184.97). Across its 52-week range of $121.06 to $244.89, MOH sits at the 67.6% percentile with a 14-day RSI of 46.2 (NEUTRAL RANGE) and an implied next-earnings move of ±9.3% ($185.74 to $223.82).
MOH Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is MOH stock moving today?
Why MOH Stock surged +2.93% Today — RQD Quant Desk Flash. Stretched risk/reward at 22x P/E (17% return on capital) under elevated 10-year interest-rate pressure.
ROARABLE RATING BRIEF • RQD 54/100 (D+)
✓ STAGE-C NUMBER FIREWALL VERIFIED
MOH — Molina Healthcare Inc: What the Facts Mean to a Prospective Investor
Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:16:24Z
Roarable Rating Brief: What This Means to a Prospective Investor
Per the Roarable RQD rating, MOH scores 54 out of 100 with a letter grade of D+ and a verdict label of "Roarable Sell — Weak Fundamentals / Trim." The five pillars are: Fundamental Cash Engine at 10 of 20 (ROIC 17.2%; FCF yield -6.12%); Whale 13F Flow at 11 of 20 (institutional accumulation and options positioning); Insider Conviction at 9 of 20 (SEC Form 4 and Congressional PTR cluster flow); Macro Regime Fit at 10 of 20 (Beta 0.94; sector sensitivity); and Forensic Balance Sheet at 14 of 20 (Altman Z 4.34; Piotroski F 4/9; Debt/Equity 0.93). The strongest pillar is the forensic balance sheet, while the cash engine and macro fit pillars sit at half marks, and insider conviction is the weakest relative to its weight. For a prospective investor, the rating frames the stock as one where the reported return on invested capital is respectable but negative free cash flow yield and thin margins temper the case. Valuation metrics per the market data (P/E TTM 22, forward P/E 20.5) indicate the market is pricing in earnings recovery, a tradeoff the rating does not endorse. Upside drivers would need to come from margin repair and cash conversion; the rating's cautious verdict reflects that those improvements are not yet visible in the source data. This is an analytical summary, not personalized financial advice.
Snapshot
Financial Trend
| Period | Revenue | Operating Income | Net Income | EPS | FCF | Cash | Debt |
|---|---|---|---|---|---|---|---|
| FY 2025 | $45426.0M | $781.0M | $472.0M | N/A | $-636.0M | $4248.0M | $3766.0M |
| FY 2024 | $40650.0M | $1707.0M | $1179.0M | N/A | $544.0M | $4662.0M | $2923.0M |
| FY 2023 | $34072.0M | $1573.0M | $1091.0M | N/A | $128.8M | N/A | $9567.4M |
Per the market data, gross margin is 13.1%, operating margin 1.7%, and net margin 1%, with ROIC at 17.2%. Per the SEC financials, revenue rose from $34072.0M (FY 2023) to $45426.0M (FY 2025), while net income declined from $1179.0M (FY 2024) to $472.0M (FY 2025) and FCF moved to $-636.0M. Per the Roarable RQD rating, the Altman Z-Score is 4.34, the Piotroski F-Score is 4/9, and Debt/Equity is 0.93. Cash of $4248.0M against debt of $3766.0M is reported for FY 2025.
Recent Catalysts & News Wire Analysis
Per the recent news feed, five MOH items appear: a Yahoo Finance piece on the stock possibly trading at a discount despite reaffirmed 2026 guidance (YELLOW); a Forbes item (YELLOW); a Seeking Alpha piece characterizing the valuation as paying a premium for an unrealized recovery (YELLOW); a TradingView report that Q3 2026 sales topped estimates (YELLOW); and a Simply Wall St item on the stock looking reasonable relative to its sales base (YELLOW). A Yahoo Finance item flagged RED under RISK WATCH reports the stock dropping after Q3 results exposed a margin squeeze. The feed therefore contains mixed signals: a guidance reaffirmation and a sales beat alongside a margin-focused selloff. The Butterfly Supply-Chain Graph reports no supply chain links and no proprietary signals.
Open Questions
- What specific drivers account for the margin squeeze flagged in the Q3 news item, and how do they reconcile with the reaffirmed 2026 guidance?
- What is the composition of revenue and the medical cost trend behind the gap between FY 2024 and FY 2025 net income?
- Why is FY 2025 FCF negative, and is that expected to reverse?
- What is the EPS history, since reported EPS is N/A across all periods?
- Who are the institutional holders and insiders, and what is their recent activity?
MOH Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for Molina Healthcare Inc (MOH) • Click "Debate This Headline" to argue it in the Roar Pit below
🟡 MARKET WIRE Yahoo Finance • 13h ago
Molina Healthcare (MOH) Stock May Trade At A Discount Despite Reaffirmed 2026 Guidance Yahoo Finance report covering Molina Healthcare Inc (MOH) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Forbes • 16h ago
Molina Healthcare Forbes report covering Molina Healthcare Inc (MOH) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Seeking Alpha • 19h ago
Molina Healthcare: Paying 21x For A Recovery That Hasn't Happened Yet Seeking Alpha report covering Molina Healthcare Inc (MOH) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE TradingView • 22h ago
Molina Healthcare’s (NYSE:MOH) Q3 2026 sales top estimates TradingView report covering Molina Healthcare Inc (MOH) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Simply Wall St • 1d ago
Molina Healthcare (MOH) Stock May Look Reasonable On Its Sales Base Simply Wall St report covering Molina Healthcare Inc (MOH) market action, institutional positioning, and fundamental catalysts.
🔴 RISK WATCH Yahoo Finance • 1d ago
Molina Healthcare (MOH) Stock Drops After Q3 Results Expose Margin Squeeze Yahoo Finance report covering Molina Healthcare Inc (MOH) market action, institutional positioning, and fundamental catalysts.
🔴 RISK WATCH GuruFocus • 1d ago
Molina Healthcare Inc (MOH) Shares Fall 3.5% -- What GF Score of 80 Tells Investors GuruFocus report covering Molina Healthcare Inc (MOH) market action, institutional positioning, and fundamental catalysts.
🟢 CATALYST GuruFocus • 1d ago
Molina Healthcare (MOH) Shares Dip After Q3 Beat Despite Strong Revenue Growth GuruFocus report covering Molina Healthcare Inc (MOH) market action, institutional positioning, and fundamental catalysts.
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE
3 Active Posts & Replies
MOH Bull vs. Bear Conversation Board — What's Your Call at $204.78?
🐂 50% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON MOH 🐻 50% BEARISH CONVICTION
RO RoarDesk_Moderator Roarable Research Desk ⚖️ DEBATE HOST
🎯 Target: $214.87 (+8.0%)
📌 Pinned Debate 🔥 Official Bull vs. Bear Debate: Is MOH (D+ • RQD 54/100) a Buy at $198.95?
Welcome to the MOH (Molina Healthcare Inc) Roar Pit. Current RQD Composite is 54/100 (Roarable Sell — Weak Fundamentals / Trim) in Medical Specialities. Bulls point to capital efficiency (17.2% ROIC), while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.
SK SkepticalCFA Forensic Accounting Watch 🐻 BEARISH
🎯 Target: $163.14 (-18.0%)
Spot @ $198.95 Pump the brakes on MOH — check the valuation vs. margin headwinds
Everyone in here is repeating the bull case on MOH, but look at what you are paying: 22.0x trailing P/E with 13.1% gross margins. Unless Molina Healthcare Inc expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.
DE DeltaGamma_99 Verified K Arena Trader 🐂 BULLISH
🎯 Target: $250.68 (+26.0%)
Spot @ $198.95 MOH cash flow & RQD setup is being underpriced by the Street here
Looking at the 5-pillar RQD breakdown on MOH, the market is fixating on short-term headline noise in Medical Specialities and ignoring the balance sheet and cash flow trajectory. At $198.95 (52-wk range $121.06 - $244.89), any beat on forward guidance forces shorts and underweight funds to chase.